Skip to content

Reference information only. Therapept does not sell peptides and does not provide medical advice.Research-use notice

Therapept

Laboratory record

Prodigy Labs

Publishes method detail and pricing per tier for peptide work: reversed-phase HPLC purity at 214 or 220 nm reported as main-peak area percent, LC-MS identity by electrospray ionisation, LAL or recombinant Factor C endotoxin in EU/mg, and a 14-day USP <71> sterility run stated as performed in-house.

San Diego, California, United States

Published capabilities

Recorded from the laboratory’s own live pages. “Not stated” means the laboratory has not published a position — it is not a statement that the service is unavailable.

Peptide-specific testing
Yes
HPLC
Yes
LC-MS
Yes
Mass spectrometry
Yes
Identity
Yes
Purity
Yes
Amino acid analysis
Not stated
Endotoxin
Yes
Sterility
Yes

Accreditation and working terms

Accreditation
Self-reported: “accredited to ISO/IEC 17025:2017 by PJLA under Accreditation #96417 (Certificate #L26-715)”, with the laboratory's own qualifier on its peptide page that “not every service is in scope.” Not yet confirmed on PJLA's public register.Self-reported
Turnaround time
Published per tier: 5–7 business days for identity and purity; 7–10 for injectable screening; approximately 15 for injectable release including USP <71> sterility.
Sample requirements
Not publicly stated — confirmed per enquiry within 1–2 business days.
Report policy
COA issued to the customer, with a public COA verification portal.

Sources

  1. Prodigy Labs — peptide testingMethods, tiers, pricing and turnaround read from the live page on 3 September 2026.
  2. PJLA — accredited organisation searchThe register should be used to confirm accreditation #96417 and its scope. Not yet confirmed by Therapept.

Last reviewed 3 September 2026 · Report an inaccuracy in this record